Celldex Therapeutics Inc
F:TCE2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celldex Therapeutics Inc
F:TCE2
|
US |
|
dotDigital Group PLC
OTC:DOTDF
|
UK |
|
ASE Technology Holding Co Ltd
NYSE:ASX
|
TW |
|
F
|
Fujikura Ltd
XBER:FJK
|
JP |
|
C
|
Cassava Sciences Inc
SWB:PX91
|
US |
|
N
|
Nomura Holdings Inc
SGX:N33
|
JP |
|
E
|
ENEOS Holdings Inc
XMUN:JHJ
|
JP |
|
F
|
Forte Biosciences Inc
F:37TA
|
US |
|
K
|
Konami Group Corp
SWB:KOA
|
JP |
|
Xantippe Resources Ltd
ASX:XTC
|
AU |
|
C
|
Coca-Cola Europacific Partners PLC
AEX:CCEP
|
UK |
|
Banco de Sabadell SA
MAD:SAB
|
ES |
|
S
|
Swatch Group AG
DUS:UHR
|
CH |
|
Commerzbank AG
MIL:CBK
|
DE |
|
Teradyne Inc
NASDAQ:TER
|
US |
|
V
|
Vector Group Ltd
SWB:VGR
|
US |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
OTC:MDIBF
|
IT |
|
AXA SA
MIL:1CS
|
FR |
|
Alphawave IP Group PLC
F:7GL
|
UK |
|
America Movil SAB de CV
F:MV91
|
MX |
|
C
|
Credicorp Ltd
BMV:BAPN
|
PE |
|
O
|
OM2 Network Co Ltd
TSE:7614
|
JP |
|
Avex Inc
TSE:7860
|
JP |
|
B
|
Bayan Resources Tbk PT
SWB:BNB
|
ID |
Discount Rate
TCE2 Cost of Equity
Discount Rate
TCE2's Cost of Equity, calculated using the formula Risk-Free Rate + Beta x ERP, stands at 9.6%. The Beta, indicating the stock's volatility relative to the market, is 1.13, while the current Risk-Free Rate, based on government bond yields, is 4.74%, and the ERP, measuring the extra return over the risk-free rate required by investors, is 4.3%.
TCE2 WACC
Discount Rate
TCE2's Weighted Average Cost of Capital (WACC) is calculated as the weighted average of its cost of equity and cost of debt, adjusted for tax. The WACC stands at 9.6%. This includes the cost of equity at 9.6%, calculated as Risk-Free Rate + Beta x ERP, and the cost of debt at 8.56%, reflecting the interest rate on TCE2's debt adjusted for tax benefits. The weight of debt in the capital structure is 0%.
What is TCE2's discount rate?
TCE2's current Cost of Equity is 9.6%, while its WACC stands at 9.6%. The selection of the appropriate discount rate is contingent on the type of cash flows being discounted.
For Equity Valuation: When valuing equity, especially in scenarios where you are discounting cash flows to equity holders (such as Net Income, Earnings Per Share (EPS), or Free Cash Flow to Equity), the Cost of Equity should be used.
For Firm Valuation: In contrast, when valuing the entire firm and discounting cash flows available to both debt and equity holders (like Free Cash Flow to the Firm), the Weighted Average Cost of Capital (WACC) is the appropriate rate.
How is Cost of Equity for TCE2 calculated?
The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP).
This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk.
Here is how we calculate the cost of equity for
TCE2
How is WACC for TCE2 calculated?
WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company’s entire operations.
The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure.
Here is how we calculate WACC for
TCE2
